Logo image of SRT

StarTek Inc (SRT) Stock Fundamental Analysis

NYSE:SRT - US85569C1071 - Common Stock

4.42 USD
+0.05 (+1.14%)
Last: 1/4/2024, 8:25:49 PM
4.5223 USD
+0.1 (+2.31%)
After Hours: 1/4/2024, 8:25:49 PM
Fundamental Rating

3

Taking everything into account, SRT scores 3 out of 10 in our fundamental rating. SRT was compared to 83 industry peers in the IT Services industry. Both the profitability and financial health of SRT have multiple concerns. SRT is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SRT was profitable.
In the past year SRT had a positive cash flow from operations.
In the past 5 years SRT reported 4 times negative net income.
Each year in the past 5 years SRT had a positive operating cash flow.
SRT Yearly Net Income VS EBIT VS OCF VS FCFSRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M 60M

1.2 Ratios

With a Return On Assets value of -5.82%, SRT perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
SRT's Return On Equity of -12.62% is in line compared to the rest of the industry. SRT outperforms 47.62% of its industry peers.
SRT has a Return On Invested Capital of 1.55%. This is comparable to the rest of the industry: SRT outperforms 50.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SRT is significantly below the industry average of 22.73%.
Industry RankSector Rank
ROA -5.82%
ROE -12.62%
ROIC 1.55%
ROA(3y)-2.19%
ROA(5y)-2.58%
ROE(3y)-6.77%
ROE(5y)-7.5%
ROIC(3y)3.42%
ROIC(5y)2.81%
SRT Yearly ROA, ROE, ROICSRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -10 -20 -30

1.3 Margins

SRT has a Operating Margin (1.79%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of SRT has declined.
SRT has a Gross Margin of 15.62%. This is amonst the worse of the industry: SRT underperforms 91.67% of its industry peers.
SRT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.79%
PM (TTM) N/A
GM 15.62%
OM growth 3Y-7.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.8%
GM growth 5Y6.27%
SRT Yearly Profit, Operating, Gross MarginsSRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 5 -5 10 15

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SRT is destroying value.
The number of shares outstanding for SRT has been reduced compared to 1 year ago.
Compared to 1 year ago, SRT has a worse debt to assets ratio.
SRT Yearly Shares OutstandingSRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
SRT Yearly Total Debt VS Total AssetsSRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.09, we must say that SRT is in the distress zone and has some risk of bankruptcy.
SRT has a Altman-Z score of 1.09. This is in the lower half of the industry: SRT underperforms 66.67% of its industry peers.
SRT has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.38, SRT is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.09
ROIC/WACC0.15
WACC10.25%
SRT Yearly LT Debt VS Equity VS FCFSRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.24 indicates that SRT should not have too much problems paying its short term obligations.
The Current ratio of SRT (1.24) is worse than 61.90% of its industry peers.
SRT has a Quick Ratio of 1.24. This is a normal value and indicates that SRT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of SRT (1.24) is worse than 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.24
SRT Yearly Current Assets VS Current LiabilitesSRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.78% over the past year.
The Revenue has decreased by -1.34% in the past year.
Measured over the past years, SRT shows a small growth in Revenue. The Revenue has been growing by 5.65% on average per year.
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%154.55%
Revenue 1Y (TTM)-1.34%
Revenue growth 3Y-16.35%
Revenue growth 5Y5.65%
Sales Q2Q%-42.61%

3.2 Future

Based on estimates for the next years, SRT will show a decrease in Earnings Per Share. The EPS will decrease by -5.55% on average per year.
SRT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -22.85% yearly.
EPS Next Y-5.73%
EPS Next 2Y-5.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-43.56%
Revenue Next 2Y-22.85%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SRT Yearly Revenue VS EstimatesSRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SRT Yearly EPS VS EstimatesSRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 -0.5 -1

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.41, the valuation of SRT can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of SRT indicates a rather cheap valuation: SRT is cheaper than 96.43% of the companies listed in the same industry.
SRT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.24.
Based on the Price/Forward Earnings ratio of 8.26, the valuation of SRT can be described as reasonable.
Based on the Price/Forward Earnings ratio, SRT is valued cheaper than 94.05% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.82, SRT is valued rather cheaply.
Industry RankSector Rank
PE 6.41
Fwd PE 8.26
SRT Price Earnings VS Forward Price EarningsSRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

76.19% of the companies in the same industry are more expensive than SRT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.37
SRT Per share dataSRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as SRT's earnings are expected to decrease with -5.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.55%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

StarTek Inc

NYSE:SRT (1/4/2024, 8:25:49 PM)

After market: 4.5223 +0.1 (+2.31%)

4.42

+0.05 (+1.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-09 2023-11-09/amc
Earnings (Next)03-25 2024-03-25/amc
Inst Owners0%
Inst Owner Change-99.99%
Ins Owners53.85%
Ins Owner Change0%
Market Cap178.35M
Analysts80
Price Target5 (13.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)45.98%
Min EPS beat(2)-39.07%
Max EPS beat(2)131.02%
EPS beat(4)2
Avg EPS beat(4)59.78%
Min EPS beat(4)-39.07%
Max EPS beat(4)155.78%
EPS beat(8)4
Avg EPS beat(8)80.96%
EPS beat(12)5
Avg EPS beat(12)49.64%
EPS beat(16)6
Avg EPS beat(16)-4.09%
Revenue beat(2)1
Avg Revenue beat(2)0.45%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)2.88%
Revenue beat(4)2
Avg Revenue beat(4)-20.63%
Min Revenue beat(4)-85.59%
Max Revenue beat(4)2.88%
Revenue beat(8)2
Avg Revenue beat(8)-37.56%
Revenue beat(12)5
Avg Revenue beat(12)-23.3%
Revenue beat(16)8
Avg Revenue beat(16)-16.68%
PT rev (1m)0%
PT rev (3m)3.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.86%
EPS NY rev (1m)0%
EPS NY rev (3m)49.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 6.41
Fwd PE 8.26
P/S 0.59
P/FCF N/A
P/OCF 20.36
P/B 1.05
P/tB N/A
EV/EBITDA 9.37
EPS(TTM)0.69
EY15.61%
EPS(NY)0.54
Fwd EY12.11%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.22
OCFY4.91%
SpS7.47
BVpS4.23
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.82%
ROE -12.62%
ROCE 2.05%
ROIC 1.55%
ROICexc 1.79%
ROICexgc 6.57%
OM 1.79%
PM (TTM) N/A
GM 15.62%
FCFM N/A
ROA(3y)-2.19%
ROA(5y)-2.58%
ROE(3y)-6.77%
ROE(5y)-7.5%
ROIC(3y)3.42%
ROIC(5y)2.81%
ROICexc(3y)3.71%
ROICexc(5y)3.01%
ROICexgc(3y)9.5%
ROICexgc(5y)8.24%
ROCE(3y)4.44%
ROCE(5y)3.67%
ROICexcg growth 3Y-16.41%
ROICexcg growth 5YN/A
ROICexc growth 3Y-11.34%
ROICexc growth 5YN/A
OM growth 3Y-7.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.8%
GM growth 5Y6.27%
F-Score6
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 2.94
Cap/Depr 69.47%
Cap/Sales 3.89%
Interest Coverage 0.46
Cash Conversion 39.34%
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 1.24
Altman-Z 1.09
F-Score6
WACC10.25%
ROIC/WACC0.15
Cap/Depr(3y)52.36%
Cap/Depr(5y)49.4%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%154.55%
EPS Next Y-5.73%
EPS Next 2Y-5.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.34%
Revenue growth 3Y-16.35%
Revenue growth 5Y5.65%
Sales Q2Q%-42.61%
Revenue Next Year-43.56%
Revenue Next 2Y-22.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y575%
EBIT growth 3Y-22.43%
EBIT growth 5YN/A
EBIT Next Year80%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-180.43%
FCF growth 3Y5.24%
FCF growth 5Y8.98%
OCF growth 1Y-63.97%
OCF growth 3Y-2.19%
OCF growth 5Y9.86%